WALTER KILPATRICK: Open Payments
NPI 1376771956 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$128 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $128
Food & beverage: $128
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: REXULTI, INVEGA SUSTENNA, COBENFY, UZEDY, CAPLYTA.
Industry payments across CT — which companies pay providers there.
